NCT04257136 - VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 17, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Septic ShockSepsisHypovolemia

Interventions

DRUG

VBI-S

VBI-S is made of small particles of specific lipid called micelles and liposomes for the treatment of hypotension.

Trial Locations (8)

Mount Sinai Hospital, New York

Einstine Medical Center, East Norriton

Adventist Health Care, Silver Spring

UMD Shock Trauma, Baltimore

Henry Ford Health System, Detroit

Truman Medical Center, Kansas City

Dignity Health, Chandler

University of Arizona, Tucson